Loading clinical trials...
Loading clinical trials...
Use of Regadenoson for a Stress Echocardiogram Protocol Using Speckle Tracking Imaging
Conditions
Interventions
Regadenoson
Locations
1
United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Start Date
September 30, 2014
Primary Completion Date
June 28, 2024
Completion Date
June 28, 2024
Last Updated
October 2, 2024
NCT07472049
NCT06747117
NCT07444957
NCT06535568
NCT05955326
NCT03529019
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions